Evidence map›Paper›PMID 27753690›Full record

ReviewCurrent opinion in infectious diseases2017

Bronchiectasis and other chronic lung diseases in adolescents living with HIV.

Engi F Attia, Robert F Miller, Rashida A Ferrand

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in infectious diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Aging of adult lifetime survivors with perinatal HIV.Current opinion in HIV and AIDS · 2025
    Review
  8. Review
  9. Secondary Immunodeficiency and Non-cystic Fibrosis Bronchiectasis.Tuberculosis and respiratory diseases · 2024
    Article
  10. Article
  11. Bronchiectasis in children in a high HIV and tuberculosis prevalence setting.African journal of thoracic and critical care medicine · 2024
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Longitudinally Evaluating the Lung Function of Children in Low- and Middle-income Countries: It's About Time.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Article
  18. Adolescent tuberculosis.The Lancet. Child & adolescent health · 2020
    Review
  19. Unexpectedly High Prevalence of Cytomegalovirus DNAemia in Older Children and Adolescents With Perinatally Acquired Human Immunodeficiency Virus Infection.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2019
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Engi F AttiaaPulmonary and Critical Care Medicine, University of Washington, Seattle, Washington, USA bResearch Department of Infection and Population Health, University College London cClinical Research Department, London School of Hygiene and Tropical Medicine, London, UK dBiomedical Research and Training Institute, Harare, Zimbabwe.
Robert F Miller
Rashida A Ferrand
London School of Hygiene & Tropical Medicine · GBUniversity of London · GBUniversity of Washington · US

Funding

Risk Factors for Abnormal Spirometry Among HIV+ Individuals in Nairobi, KenyaF32HL125031 · NHLBI · UNIVERSITY OF WASHINGTON · PI ATTIA, ENGI FAROUK · 2014 to 2014
$54k
NHLBI NIH HHS F32 HL125031Wellcome Trust
6 · The paper itself

Abstract

purpose of reviewThe incidence of pulmonary infections has declined dramatically with improved access to antiretroviral therapy (ART) and cotrimoxazole prophylaxis, but chronic lung disease (CLD) is an increasingly recognized but poorly understood complication in adolescents with perinatally acquired HIV. RECENT

findingsThere is a high prevalence of chronic respiratory symptoms, abnormal spirometry and chest radiographic abnormalities among HIV-infected adolescents in sub-Saharan Africa, wherein 90% of the world's HIV-infected children live. The incidence of lymphocytic interstitial pneumonitis, the most common cause of CLD in the pre-ART era, has declined with increased ART access. Small airways disease, particularly constrictive obliterative bronchiolitis and bronchiectasis, are emerging as leading causes of CLD among HIV-infected adolescents in low-income and middle-income countries. Asthma may be more common in high-income settings. Likely risk factors for CLD include recurrent pulmonary infections, air pollution, HIV-related immune dysfunction, and untreated HIV infection, particularly during critical stages of lung development. SUMMARY: Globally, the importance of HIV-associated CLD as a cause of morbidity and mortality is increasing, especially as survival has improved dramatically with ART and growing numbers of children living with HIV enter adolescence. Further research is urgently needed to elucidate the natural history and pathogenesis of CLD, and to determine optimal screening, diagnostic and treatment strategies.

Indexed as

AdolescentAfrica South of the SaharaBronchiectasisChronic DiseaseHIV InfectionsHumansLung DiseasesLung Diseases, InterstitialPulmonary Disease, Chronic Obstructive

Identifiers

PMID27753690
PMCPMC5408733
OpenAlexW2529813951

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.